SAN DIEGO, Jan. 31, 2021 /PRNewswire/ — Shareholder rights regulation agency Johnson Fistel, LLP is investigating potential violations of the federal securities legal guidelines by iRhythm Applied sciences, Inc. (“iRhythm” or the “Firm”) (NASDAQ: IRTC).
iRhythm inventory suffered a steep decline following the Facilities for Medicare and Medicaid Providers (CMS) announcement concerning its 2021 Medicare Doctor Payment Schedule (MPFS) Ultimate Rule. The MPFS Ultimate Rule establishes the fee insurance policies and charges that Medicare will use subsequent 12 months. Johnson Fistel’s investigation seeks to find out whether or not the Firm issued false or deceptive statements or did not disclose info related to buyers.
When you have info that might help on this investigation, or if you’re an iRhythm shareholder and are serious about studying extra concerning the investigation, please contact Jim Baker ([email protected]) at 619-814-4471. If emailing, please embrace a cellphone quantity.
Moreover, you may [click here to join this action]. There isn’t any value or obligation to you.
About Johnson Fistel, LLP:
Johnson Fistel, LLP is a nationally acknowledged shareholder rights regulation agency with workplaces in California, New York and Georgia. The agency represents particular person and institutional buyers in shareholder by-product and securities class motion lawsuits. For extra details about the agency and its attorneys, please go to http://www.johnsonfistel.com. Legal professional promoting. Previous outcomes don’t assure future outcomes.
SOURCE Johnson Fistel, LLP